Senior Director, Head of Molecular Biomedicine, Research & Early Development
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Ballerup
LEO Pharma has embarked on an ambitious journey to become the world’s preferred dermatology care partner. You will enter LEO Pharma at the most exciting time. We are transforming our business and ways of working to meet the requirements of tomorrow and our corporate 2030 strategy.
Global Research and Development (R&D) is at the forefront of this journey – and that is why we need you.
We are looking for a Senior Director and Head of Molecular Biomedicine, who will take up the overall responsibility of supporting first in class or best in class drug candidates to the pipeline as well as late stage scientific pipeline support.
You will report directly to VP Head of Research & Early Development and will be a part of the leadership team of Research & Early Development. As part of the leadership team, you will act as a role model in building our capabilities even further, while at the same time ensuring efficiency and effectiveness -and challenging the status quo.
As a Senior Director you will head up a function of 35 employees who are divided into four departments within in vitro biology, target biology, protein technology and bioinformatics, lead by four leaders. In close collaboration with your leaders, you will be responsible for continuously developing and supporting the R&D pipeline and partner with various internal and external teams to deliver on our ambitious goals.
In your leadership role, you will be accountable for the following areas:
To be successful in this role, we envision that you hold a PhD in the areas of molecular biology, biochemistry other areas related to drug discovery such as biological chemistry or pharmacy. You have at least 10 years industrial experience in drug discovery and have a track record of bringing small molecule candidates to clinical testing.
You have a minimum of 8 years of experience leading high-performance teams and a strong track record of developing talents. You have an international mindset and outlook, and you are known for your open and positive mindset. You find it motivating to work with people development and helping others to perform and deliver on ambitious goals. You have an excellent ability to identify, prioritize and focus on key challenges and a strong drive for results. Additionally, you understand the importance of creating data driven, agile and innovative work processes, securing an inflow of internal and external innovation into the portfolio, in addition to progressing the portfolio with the highest speed and quality according to LEO Pharma’s overall ambitions.
You have solid stakeholder management and communication skills and you are able to communicate effectively with colleagues from a variety of scientific and business disciplines. Additionally, you can manage ambiguity effectively and have a good understanding of team dynamics and how to promote and support a constructive collaboration.
Join our mission to help more people achieve healthy skin
Hundreds of millions of people around the globe are suffering from an untreated skin disease. Helping these people to get a better life is what LEO Pharma is all about. By understanding their needs and wishes we will improve existing treatments and break new land to uncover the solutions of tomorrow.
By joining LEO Pharma you will get the opportunity to create results, develop yourself among highly skilled colleagues while taking on our quest to become the preferred dermatology care partner improving people’s lives around the world and at the same time create profitable growth.
Contact and application
If you have questions, please do not hesitate to contact Thorsten Thormann, VP Head of Research & Early Development, at +45 40 74 82 44.
. The deadline is 20 February 2022. We will be reviewing applications and conduct interviews on an ongoing basis.
About LEO Pharma
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 6,000 people worldwide. For more information, visit www.leo-pharma.com.
Global Research and Development (R&D) is at the forefront of this journey – and that is why we need you.
We are looking for a Senior Director and Head of Molecular Biomedicine, who will take up the overall responsibility of supporting first in class or best in class drug candidates to the pipeline as well as late stage scientific pipeline support.
You will report directly to VP Head of Research & Early Development and will be a part of the leadership team of Research & Early Development. As part of the leadership team, you will act as a role model in building our capabilities even further, while at the same time ensuring efficiency and effectiveness -and challenging the status quo.
Leading the Molecular Biomedicine function to the next level
As a Senior Director you will head up a function of 35 employees who are divided into four departments within in vitro biology, target biology, protein technology and bioinformatics, lead by four leaders. In close collaboration with your leaders, you will be responsible for continuously developing and supporting the R&D pipeline and partner with various internal and external teams to deliver on our ambitious goals.
In your leadership role, you will be accountable for the following areas:
- Set strategic direction, build and enhance capabilities within drug discovery to ensure implementation of our Drug Discovery strategy with focus on small molecules for oral delivery.
- Lead the Molecular Biomedicine function through transformation and change by leading by example and setting the framework for a transparent, efficient and agile working environment.
- Lead Molecular Biomedicine function to identify new promising biological targets and to build, validate and operate biological assay platform. Furthermore, to ensure that we have a biomarker strategy and platform to enable optimal positioning of clinical pipeline projects.
- Drive R&D project decisions through the committee memberships below from early stage to human Proof of Concept stage gate projects concerning Molecular Biomedicine.
- Support clinical stage projects with MoA studies.
- Oversee and set direction for external/sourced FTEs in close collaboration with the leaders of the departments.
- Be a thought leader by building and maintaining strong external network with key opinion leaders in the field capture external trends.
Experienced leadership profile with a strong scientific background within drug discovery
To be successful in this role, we envision that you hold a PhD in the areas of molecular biology, biochemistry other areas related to drug discovery such as biological chemistry or pharmacy. You have at least 10 years industrial experience in drug discovery and have a track record of bringing small molecule candidates to clinical testing.
You have a minimum of 8 years of experience leading high-performance teams and a strong track record of developing talents. You have an international mindset and outlook, and you are known for your open and positive mindset. You find it motivating to work with people development and helping others to perform and deliver on ambitious goals. You have an excellent ability to identify, prioritize and focus on key challenges and a strong drive for results. Additionally, you understand the importance of creating data driven, agile and innovative work processes, securing an inflow of internal and external innovation into the portfolio, in addition to progressing the portfolio with the highest speed and quality according to LEO Pharma’s overall ambitions.
You have solid stakeholder management and communication skills and you are able to communicate effectively with colleagues from a variety of scientific and business disciplines. Additionally, you can manage ambiguity effectively and have a good understanding of team dynamics and how to promote and support a constructive collaboration.
Join our mission to help more people achieve healthy skin
Hundreds of millions of people around the globe are suffering from an untreated skin disease. Helping these people to get a better life is what LEO Pharma is all about. By understanding their needs and wishes we will improve existing treatments and break new land to uncover the solutions of tomorrow.
By joining LEO Pharma you will get the opportunity to create results, develop yourself among highly skilled colleagues while taking on our quest to become the preferred dermatology care partner improving people’s lives around the world and at the same time create profitable growth.
Contact and application
If you have questions, please do not hesitate to contact Thorsten Thormann, VP Head of Research & Early Development, at +45 40 74 82 44.
. The deadline is 20 February 2022. We will be reviewing applications and conduct interviews on an ongoing basis.
About LEO Pharma
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 6,000 people worldwide. For more information, visit www.leo-pharma.com.
Information og data
Denne ledige stilling har jobtypen "Direktør", og befinder sig i kategorien "Ledelse og personale".
Arbejdsstedet er beliggende i Ballerup.
Jobbet er oprettet på vores service den 26.1.2022, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Direktør
- Ballerup
- Søndag den 20. februar 2022
Lignende jobs
-
Senior Director, Global Regulatory Affairs, Team L...
At [xxxxx], we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and th..Få mere info- Direktør
- København
-
CLOSED - Branchedirektør til Træ- og Møbelindustri...
STILLINGEN ER BESAT OG KAN IKKE LÆNGERE ANSØGESSom branchedirektør for Træ- og Møbelindustrien (TMI) skal du medvirke til udvikling af brancheforeningen for danske design- og produktionsvirksom..Få mere info- Direktør
- København
-
Direktør til Dansk Producentansvar (DPA)
DPA er en selvejende, nonprofitorganisation, som varetager en række myndigheds- og registeropgaver knyttet til producentansvar i henhold til Miljøbeskyttelsesloven herunder emballage, elektronik m..Få mere info- Direktør
- København
-
Associate Director, Global Regulatory Affairs - CM...
At [xxxxx], we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and th..Få mere info- Direktør
- København
Statistik over udbudte jobs som direktør i Ballerup
Herunder ser du udviklingen i udbudte direktør i Ballerup over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal direktør.
Se flere statistikker her:
Statistik over udbudte direktør i Ballerup over tid
| Dato | Alle jobs som direktør |
|---|---|
| 11. november 2024 | 2 |
| 10. november 2024 | 2 |
| 9. november 2024 | 2 |
| 8. november 2024 | 2 |
| 7. november 2024 | 2 |
| 6. november 2024 | 2 |
| 5. november 2024 | 2 |
| 4. november 2024 | 2 |
| 3. november 2024 | 2 |
| 2. november 2024 | 2 |
| 1. november 2024 | 2 |
| 31. oktober 2024 | 2 |
| 30. oktober 2024 | 2 |
| 29. oktober 2024 | 2 |
| 28. oktober 2024 | 2 |
| 27. oktober 2024 | 2 |
| 26. oktober 2024 | 2 |
| 25. oktober 2024 | 2 |
| 24. oktober 2024 | 2 |